Inotiv Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Inotiv Inc in the second quarter 2026?
Inotiv Inc recorded a cumulative net loss of $-87 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -74.67%.

Within the Medical Laboratories industry 29 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2842 to 3394.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter
Y / Y Equity Change	-51.11 %	-35.8 %	-20.22 %	-21.04 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-87	-69	-69	-80	-88
Return On Equity (TTM)	-74.67 %	-50.77 %	-45.2 %	-49.76 %	-51.96 %
NOTV's Total Ranking	# 3394	# 2842	# 2784	# 2543	# 2402
Equity (TTM) in Millions	77	109	136	144	158
Seq. Equity Change	-29.28 %	-19.85 %	-5.39 %	-8.82 %	-7.15 %
Seq. Net Income Change	-	-	-	-	-

Back to NOTV Management Effectiveness >> NOTV's 5 Years Annual ROE >> Compare NOTV ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 30
Sector	# 500
Overall	# 3394

Return On Equity Statistics
High	Average	Low
20.42 %	-24.05 %	-113.94 %
(Sep 30 2021)		(Jun 30 2023)

NOTV Annual Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Equity in Millions	136	171	268	360	105
Y / Y Equity Change	-20.22 %	-36.5 %	-25.37 %	242.22 %	1283.99 %
Net Income in Millions	-69	-109	-105	-337	11
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-50.45 %	-63.86 %	-39.07 %	-93.61 %	10.36 %

Back to NOTV Management Effectiveness >> NOTV's 5 Years Annual ROE >> Compare NOTV ROE to its Competitors

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NOTV's' Return on Equity at Yahoo Finance
NOTV's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NOTV's Competitors
Subscribers only: Roe for Inotiv Inc 's Suppliers
Subscribers only: Return On Equity for NOTV's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector

ROE

Date modified: 2026-09-26T06:55:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.